Tag: melphalan flufenamide

$Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma$

Phase II O-12-M1: Melflufen plus dexamethasone showed benefits in long-term survival outcomes in relapsed/refractory multiple myeloma

byKathleen Lau

February 5, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

An electronic intervention may increase chances of benzodiazepine cessation
Fremanezumab reduces migraine frequency in children and adolescents with episodic migraine
Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology

No Result

View All Result